Jianfeng Guo

No ORCID on file · 3 papers in corpus
other 2021
Resumption of the treatment of non-COVID-19 gynecologic patients after lifting lockdown: Triage and infection prevention experiences from Wuhan
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14917

AIM: To share our experiences of resuming the treatments for gynecologic patients after lifting the lockdown in a hotspot area for the Coronavirus Disease 2019 (COVID-19) pandemic. METHODS: The triage process used to resume medical activit…

lab-animal 2017
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
OncoTargets and therapy ·doi:10.2147/ott.s134784

Aberrant histone methylation contributes to the progression and development of many tumors. Histone methylation is a dynamic process regulated by both histone demethylase and histone methyltransferase, which ultimately alters the levels of …

lab-animal 2011
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
Carcinogenesis ·doi:10.1093/carcin/bgr230

Omentum metastasis is a common occurrence in epithelial ovarian cancer (EOC), which is often accompanied by ascites that facilitates the spread of EOC cells. A subpopulation of fibroblasts-the cancer-associated fibroblasts (CAFs) are import…